Biotech Platform Benchling Raises $14.5 Million
June 15, 2018
4:05 pm
Benchling, a data management and collaboration platform built to advance life sciences research, closed $14.5 million in Series B funding led by Benchmark, with participation from F-Prime Capital, a global venture capital firm associated with Fidelity Investments, and returning investor Thrive Capital. Benchmark General Partner